Epi proColon® for Colorectal Cancer Screening: A Profile of Its Use in the USA-Reference-Cited by-同舟云学术

Epi proColon® for Colorectal Cancer Screening: A Profile of Its Use in the USA

Published:2020-06-18 Issue:4 Volume:24 Page:497-503
ISSN:1177-1062
Container-title:Molecular Diagnosis & Therapy
language:en
Short-container-title:Mol Diagn Ther

Author:

Shirley Matt

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40291-020-00473-8.pdf

Reference25 articles.

1. U.S. Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(23):2564–75.

2. American Cancer Society. Colorectal cancer facts & figures 2020–2022. 2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2020-2022.pdf . Accessed 21 May 2020.

3. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.

4. Jones RM, Woolf SH, Cunningham TD, et al. The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med. 2010;38(5):499–507.

5. Adler A, Geiger S, Keil A, et al. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol. 2014;14:183.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on trends in development and translation of omics signatures in cancer;Computational and Structural Biotechnology Journal;2024-12

2. Liquid Biopsy in the Clinical Management of Cancers;International Journal of Molecular Sciences;2024-08-06

3. Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology;Current Issues in Molecular Biology;2024-06-27

4. Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients;npj Genomic Medicine;2024-05-29

5. BCAT1 , IKZF1 and SEPT9 : methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas;Biomarkers;2024-04-22